Compare MEDINOVA DIA with CHOKSI LAB. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MEDINOVA DIAG. vs CHOKSI LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MEDINOVA DIAG. CHOKSI LAB. MEDINOVA DIAG./
CHOKSI LAB.
 
P/E (TTM) x 12.4 -3.9 - View Chart
P/BV x - 0.8 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 MEDINOVA DIAG.   CHOKSI LAB.
EQUITY SHARE DATA
    MEDINOVA DIAG.
Mar-21
CHOKSI LAB.
Mar-21
MEDINOVA DIAG./
CHOKSI LAB.
5-Yr Chart
Click to enlarge
High Rs3112 253.3%   
Low Rs117 160.3%   
Sales per share (Unadj.) Rs12.836.9 34.6%  
Earnings per share (Unadj.) Rs1.9-3.7 -51.0%  
Cash flow per share (Unadj.) Rs2.62.9 91.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-7.225.5 -28.3%  
Shares outstanding (eoy) m9.986.97 143.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.70.3 632.8%   
Avg P/E ratio x11.1-2.6 -429.8%  
P/CF ratio (eoy) x8.13.4 238.9%  
Price / Book Value ratio x-2.90.4 -773.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m21167 313.9%   
No. of employees `000NANA-   
Total wages/salary Rs m17108 16.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m127257 49.6%  
Other income Rs m15 27.9%   
Total revenues Rs m129262 49.2%   
Gross profit Rs m3041 72.8%  
Depreciation Rs m746 15.6%   
Interest Rs m528 16.4%   
Profit before tax Rs m20-28 -69.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1-2 -29.0%   
Profit after tax Rs m19-26 -73.0%  
Gross profit margin %23.616.1 146.9%  
Effective tax rate %2.97.1 41.1%   
Net profit margin %14.9-10.2 -147.2%  
BALANCE SHEET DATA
Current assets Rs m16130 11.9%   
Current liabilities Rs m80162 49.0%   
Net working cap to sales %-50.2-12.4 404.2%  
Current ratio x0.20.8 24.3%  
Inventory Days Days1914 133.1%  
Debtors Days Days188115,953,978 0.0%  
Net fixed assets Rs m25518 4.9%   
Share capital Rs m10070 143.0%   
"Free" reserves Rs m-172108 -159.1%   
Net worth Rs m-72177 -40.6%   
Long term debt Rs m33288 11.4%   
Total assets Rs m41648 6.3%  
Interest coverage x5.20 147,595.0%   
Debt to equity ratio x-0.51.6 -28.0%  
Sales to assets ratio x3.10.4 788.7%   
Return on assets %58.00.3 17,871.4%  
Return on equity %-26.5-14.7 180.1%  
Return on capital %-61.80 -284,117.8%  
Exports to sales %04.6 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA12 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m012 0.0%   
Fx outflow Rs m00 0.0%   
Net fx Rs m012 0.0%   
CASH FLOW
From Operations Rs m1959 32.6%  
From Investments Rs m-3-76 4.1%  
From Financial Activity Rs m-1416 -86.0%  
Net Cashflow Rs m2-1 -207.5%  

Share Holding

Indian Promoters % 62.1 31.5 197.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 37.9 68.5 55.3%  
Shareholders   9,804 3,506 279.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MEDINOVA DIAG. With:   VIJAYA DIAGNOSTIC  TEJNAKSH HEALTHCARE  LOOKS HEALTH SERVICES  ARTEMIS MEDICARE SERVICES  SONI MEDICARE  



Today's Market

SGX Nifty Up 114 Points, FabIndia IPO, Tanla Platforms' Partnership with Vodafone Idea, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices snapped two days of losses and witnessed sharp gains as globally fears of a significant impact on economic.

Related Views on News

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

From Paytm to Reliance Power: Big IPOs with the Worst Debut Day Performance (Views On News)

Nov 22, 2021

Paytm's flop show should not come as a surprise. This is not the first time a high-profile IPO has eroded investors' wealth on listing day.

Top 5 Stocks in which FIIs Sequentially Raised their Stakes (Views On News)

Oct 26, 2021

FIIs have largely stayed on the sidelines this month, booking profits at every opportunity they get, amid tapering concerns.

India's New Drone Scheme: Watch Out for these Stocks (Views On News)

Oct 1, 2021

New drone rules and the PLI scheme is a huge confidence booster for startups and MSMEs. It will open new opportunities for drone companies.

Why Zomato Stopped its Grocery and Nutraceutical Businesses (Views On News)

Sep 13, 2021

Zomato believes its investment in Grofers will generate better results rather than its in-house grocery effort.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MEDINOVA DIAG. SHARE PRICE


Dec 8, 2021 09:49 AM

TRACK MEDINOVA DIAG.

  • Track your investment in MEDINOVA DIAG. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MEDINOVA DIAG.

MEDINOVA DIAG. 5-YR ANALYSIS

COMPARE MEDINOVA DIAG. WITH

MARKET STATS